Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Illumina, University of Washington; Great Basin; Bulldog Bio, Acqua Science; DNA Genotek; Aviagen; Excelris, IPS; Bayer CropScience, RAGT

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina said this week that the University of Washington Department of Genome Sciences has joined the Illumina Genome Network. The network is a global partnership effort linking researchers seeking large-scale, whole human genome sequencing services with institutions that provide such services using Illumina's technology.


Great Basin Corp. said this week that it has initiated its first clinical trial evaluating its molecular diagnostic test for Clostridium difficile. The privately-held firm is developing chip-based molecular diagnostic products. It expects to run trials on the C. difficile test at four sites across the US. If the trial is successful, the firm anticipates submitting a 510(k) application with the US Food and Drug Administration later this summer.


Bulldog Bio has inked a multi-year partnership to exclusively represent Acqua Science's new line of protein analytical tools in the US. The Portsmouth, NH-based firm said Acqua recently launched an eco-friendly protein gel stain that requires no pre- and post-gel processing.


DNA Genotek said that its Oragene DNA collection product is being used in the Deciphering Developmental Disorders study, a UK effort researching the genetics of children with a variety of developmental disroders. The effort hopes to recruit up to 12,000 children for the effort.


Alabama-based poultry breeding firm Aviagen has opened a new 15,000-square-feet diagnostic and research facility. Researchers at the new lab will conduct bacteriology, serology, molecular diagnostics, genomics research, and pathological exams.


Excelris, based in India, has entered into an agreement with Swiss firm IPS to identify genetic biomarkers in Fenugreek, a spice known for its medicinal value in India. The research will focus on biomarkers that are associated with high yields of important secondary metabolites which may be responsible for the spice's medicinal properties.


Bayer CropScience has licensed access to RAGT Semences' winter wheat germplasm and associated molecular markers, and the firms plan to collaborate on projects to further improve wheat breeding.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.